TSX News -
CN to Report Second-Quarter 2024 Financial and Operating Results on July 23, 2024
MONTREAL, July 08, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its second-quarter 2024 financial and operating […]
MONTREAL, July 08, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its second-quarter 2024 financial and operating […]
VANCOUVER, British Columbia, July 08, 2024 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”, “the Company”) (TSX: HOT.UN, […]
Extensive Issued and Pending IP Patent Applications Acquired with License Agreement SARASOTA, FL, July 08, 2024 (GLOBE NEWSWIRE) — Silo […]
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a […]
NEW YORK and KUALA LUMPUR, Malaysia, July 08, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“Treasure Global” or […]
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular […]
UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) in the EU for the treatment […]
GRAND CAYMAN, Cayman Islands and COIMBATORE, India, July 08, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW) (“SRIVARU” […]
According to the agreement, SciSparc’s pharmaceuticals assets are valued at approximately $11.6 million TEL AVIV, Israel, July 08, 2024 (GLOBE […]
NEW YORK and TOKYO, July 08, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]